Fennec Pharmaceuticals Inc

FRX NPV
Create an alert
Sell13.99 CAD
Buy14.16 CAD
No change
Last updated today at 19:39 UTC

Key metrics

Open-
Previous close14.22 CAD
Market capCA$511.36m
P/E ratio-
Volume46
Dividend yield0.00%
EMS-

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate, PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyCAD
  • Shares in issue34.74m

Take a closer look at this company’s financial statements and dividend information.

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.